NeuroSense Therapeutics to present at H.C. Wainwright Global Investment Conference
NRSN•Conference presentation scheduled in New York
NeuroSense Therapeutics will attend the H.C. Wainwright 28th Annual Global Investment Conference in New York City on Sept. 14-16, 2026.
A corporate presentation is scheduled for Sept. 15, 2026 at 4:30 p.m. ET, focusing on PrimeC’s ALS program and Phase 3 PARAGON plans.
